| ã€Objective】To investigate the prevention and treatment effect of intraperritoneal ligustrazine on bronchial asthma in the SD rat asthma model and the relevant mechanism.ã€Methods】The SD rat asthma model was made with classic method. All rats were divided into four groups, including asthma group (Group A, n=8), ligustrazine group (Group L, n=8), dexamethasone group (Group D, n=8), normal control group (Group N, n=8). The level of IL-4 and IL-5 in BALF were measured by ELISA. The airway inflammatory was observed with HE staining method. The expression of GATA-3 in pulmonary tissue was detected by means of immunohistochemicalstaining.ã€Results】(1) The level of IL-4 and IL-5 in BALF in Group L were much lower than those in Group A (P<0.01), there was no statistical significant difference between Group L and Group D (P>0.05). (2) The optical density of GATA-3 positive cells in pulmonary tissue in Group L was much lower than that in Group A ( P<0.01), there was no statistical significant difference between Group L and Group D(P>0.05)。ã€Conclusion】ligustrazine could lower the levels of IL-4 and IL-5 in the rat asthma model. The mechanism may be related to the action of ligustrazine to down-regulate GATA-3 expression in pulmonary tissue, resulting to suppression of Th2 reaction. |